SCHEMBL2532770

SCHEMBL2532770

O=CC(=O)C1NCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9639527 0.78
Formic Acid SCHEMBL6596895 0.77 SLC1A2 (0.33)
SCHEMBL23421623 0.77 MAPT (0.32)
SCHEMBL2532769 0.77 MAPT (0.32)
SCHEMBL28168212 0.77
SCHEMBL29039861 0.75 MAPT (0.31)
SCHEMBL2030154 0.75
SCHEMBL29039860 0.75 MAPT (0.31)
SCHEMBL8357 0.75
SCHEMBL23170 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279841-A Photocurable adhesion promoting compositions and methods of use thereof PRC-迪索托国际公司 2022-11-01 CN disclosed
CN-112220768-A Preparation method of miglitol tablets 四川维奥制药有限公司 2021-01-15 CN disclosed
EP-1801087-B1 CIS-1,2-SUBSTITUTED STILBENE DERIVATIVES FOR TREATING AND/OR PREVENTING DIABETES INST RADIATION MED AMMS PLA (CN) 2012-08-29 EP disclosed
US-8039513-B2 Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) 2011-10-18 US disclosed
US-20090161561-A1 Method and system for determining characters of channels HUAWEI TECHNOLOGIES CO., LTD 2009-06-25 US disclosed
US-20090076114-A1 Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) 2009-03-19 US disclosed
EP-1801087-A1 CIS-1,2-SUBSTITUTED STILBENE DERIVATES AND THE USE THEREROF FOR MANUFACTURING MEDICAMENTS FOR TREATING MEDICAMENTS FOR TREATING AND/OR PREVENTING DIABETES Institute of Radiation Medicine, Academy of Military Medical Sciences Pla (CN) 2007-06-27 EP disclosed